ACUTE CORONARY SYNDROMES:
TRANSLATING GUIDELINE UPDATES INTO PRACTICE

FACULTY

Christopher B. Granger, MD (Moderator)
Professor of Medicine
Director, Cardiac Care Unit
Duke University Medical Center
Durham, NC

Deepak L. Bhatt, MD
Associate Director, Cleveland Clinic Cardiovascular Coordinating Center
Associate Professor, Department of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Staff, Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH

James W. Hoekstra, MD
Professor and Chairman
Department of Emergency Medicine
Wake Forest University Health Sciences
Winston-Salem, NC

Gary L. Schaer, MD
Professor of Medicine
Rush Medical College
Director, Cardiac Catheterization Laboratories
Rush University Medical Center
Chicago, IL


 

Read frequently asked questions submitted by your peers.

Electronic newsletter now available:
Guidelines-Based Use Of Antithrombotic Agents: Applying Recent Updates To Practice

PURPOSE STATEMENT

ACUTE CORONARY SYNDROMES: TRANSLATING GUIDELINE UPDATES INTO PRACTICE will emphasize the newly updated STEMI and NSTEMI guidelines and their effect on ACS treatment strategies.

LEARNING OBJECTIVES

Upon completion, participants should be able to:

  • Discuss the most recent updates to the ACC/AHA STEMI and UA/NSTEMI guidelines
  • Summarize the results of clinical trials supporting the guideline-recommended use of anticoagulant agents for the care of patients with ACS
  • Examine efficacy and safety data from recent clinical trials of anticoagulant agents in the management of ACS

TARGET AUDIENCE

This activity is intended for clinical and interventional cardiologists, as well as emergency medicine physicians and other healthcare professionals interested in the management of acute coronary syndromes.

HARDWARE/SOFTWARE REQUIREMENTS

Operating System
Microsoft Windows® 2000, XP, Vista
Mac OS 10.1, 10.2, 10.3, 10.4

Browser
Microsoft Internet Explorer 5.5 or later
Firefox 1.5
Netscape 7 or later

Adobe Flash Player
Adobe Flash Player 7 or higher
Download the latest version at http://www.adobe.com/shockwave/download/alternates

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download the latest version at http://www.adobe.com/products/acrobat/readstep2.html

Connection Type
High bandwidth (300k) is strongly recommended
Low bandwidth (100k) results in less than optimal quality
Dial-up/modem is not recommended

For technical support, click on the Support button at www.med-iq.com

ACCREDITATION INFORMATION

Expiration date: One year from Webcast posting date

Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Med-IQ designates these educational activities for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.

Disclosure Policy
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Med-IQ requires written, signed disclosure of the existence of relevant financial interests or relationships with commercial interests within the last 12 months from any individual in a position to control the content of a CME activity sponsored by Med-IQ. Individuals who refuse to disclose relevant financial relationships will be disqualified from all aspects associated with this CME activity.

James Hoekstra, MD
Fees received for speakers’ bureau presentations for non-CME activities: sanofi-aventis U.S., Bristol-Myers Squibb, Schering-Plough Corporation

Gary L. Schaer, MD, FACC
Consulting Fees (eg, advisory boards): sanofi-aventis U.S., Bristol-Myers Squibb
Fees received for promotional services, regardless of their source (eg, speakers’ bureau presentations that are not certified for a CME activity): sanofi-aventis U.S., Bristol-Myers Squibb

Deepak Bhatt, MD, FACC, FSCAI, FESC, FACP
Research Grants (directly to the institution): Heartscape Technologies, Inc., The Medicines Company, Bristol-Myers Squibb, sanofi-aventis U.S., Eisai Inc., Ethicon Inc.
Speakers Bureau: Bristol-Myers Squibb, sanofi-aventis U.S., The Medicines Company
Honoraria: AstraZeneca, Bristol-Myers Squibb, Centocor, Inc., Eisai Inc., Eli Lilly & Company, GlaxoSmithKline, Millennium Pharmaceuticals Inc., Paringenix Inc., PDL BioPharma, sanofi-aventis U.S., Schering-Plough Corporation, The Medicines Company, TNS Healthcare, Vertex Pharmaceuticals
Institution/Employer: Abraxis BioScience, Inc., Alexion Pharma, AstraZeneca, AtheroGenics Inc., sanofi-aventis U.S., Biosense Webster, Biosite Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Boston Scientific, Bristol-Myers Squibb, CardioNet, Centocor Inc., Converge Medical Inc., Cordis, Dr. Reddy’s Laboratories, Edwards Lifesciences, Esperion Therapeutics, Inc, GE Healthcare, Genentech, Gilford Pharmaceuticals Inc., GlaxoSmithKline, Guidant, Johnson & Johnson, Kensey-Nash Corporation, Eli Lilly & Company, Medtronic, Merck & Company, Inc., Mytogen Inc., Novartis Pharmaceuticals, Novo Nordisk Pharmaceutical Industries, Inc., Orphan Therapeutics, Procter & Gamble Pharmaceuticals, Pfizer, Inc., Roche Laboratories Inc., Sankyo, sanofi-aventis U.S., Schering-Plough Corporation, Scios, St. Jude Medical, Takeda Pharmaceuticals North America, TMC, VasoGenix Pharmaceuticals Inc., Viacor Inc.

Christopher Granger, MD, FACC
Research Grant or Contract (supports University salary): Alexion Pharmaceuticals Inc, AstraZeneca, Bristol-Myers Squibb, deCODE Genetics, Genentech, GlaxoSmithKline, Novartis Pharmaceuticals, Procter & Gamble Pharmaceuticals, sanofi-aventis U.S.
Research Grant or Contract (supports my research projects): Alexion Pharmaceuticals Inc, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, deCODE Genetics, Genentech, GlaxoSmithKline, Novartis Pharmaceuticals, Procter & Gamble Pharmaceuticals, sanofi-aventis U.S., The Medicines Company
Consulting (including CME): Alexion Pharmaceuticals Inc, AstraZeneca, Genentech, Procter & Gamble Pharmaceuticals
Consulting (including non-CME): GlaxoSmithKline, INO Therapeutics Inc., Medicure, Inc., Novartis Pharmaceuticals, sanofi-aventis U.S., The Medicines Company

Med-IQ Disclosure
Reshma Carter has disclosed that her spouse is an employee of Novartis Pharmaceuticals.

All other employees of Med-IQ have no financial relationships to disclose.

Acknowledgement of Commercial Support
This educational series is supported by an educational grant from sanofi-aventis U.S.